Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Alder

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2008
N,N-Dimethyltryptamine and dichloromethane: rearrangement of quaternary ammonium salt product during GC-EI and CI-MS-MS analysisSimon D Brandt, Cláudia P B Martins, Sally Freeman, et al.
Forensic Science International|May 6, 2008
Halogenated solvent interactions with N,N-dimethyltryptamine: formation of quaternary ammonium salts and their artificially induced rearrangements during analysisSimon D Brandt, Cláudia P B Martins, Sally Freeman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2025
Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinolRoss van de Wetering, Amy F Alder, Andrew Biggerstaff, et al.
ACS Chemical Neuroscience|May 9, 2020
Synthetic Studies of Neoclerodane Diterpenes from <i>Salvia divinorum</i>: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid ReceptorRachel S Crowley, Andrew P Riley, Amy F Alder, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Physical Review Letters|July 31, 2025
Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|December 13, 2024
Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|July 31, 2025
New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|July 31, 2025
First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|August 11, 2023
First Dark Matter Search Results from the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, C W Akerlof, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2008
N,N-Dimethyltryptamine and dichloromethane: rearrangement of quaternary ammonium salt product during GC-EI and CI-MS-MS analysisSimon D Brandt, Cláudia P B Martins, Sally Freeman, et al.
Forensic Science International|May 6, 2008
Halogenated solvent interactions with N,N-dimethyltryptamine: formation of quaternary ammonium salts and their artificially induced rearrangements during analysisSimon D Brandt, Cláudia P B Martins, Sally Freeman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2025
Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinolRoss van de Wetering, Amy F Alder, Andrew Biggerstaff, et al.
ACS Chemical Neuroscience|May 9, 2020
Synthetic Studies of Neoclerodane Diterpenes from <i>Salvia divinorum</i>: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid ReceptorRachel S Crowley, Andrew P Riley, Amy F Alder, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Physical Review Letters|July 31, 2025
Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|December 13, 2024
Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|July 31, 2025
New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|July 31, 2025
First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN ExperimentJ Aalbers, D S Akerib, A K Al Musalhi, et al.
Physical Review Letters|August 11, 2023
First Dark Matter Search Results from the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, C W Akerlof, et al.
Pageof 2